Related Experiment Video
Updated: Mar 12, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Prescription precision: Evaluating antimicrobial prescription practices in paediatric and neonatal inpatients
Carla Theron1, Maja van Aswegen1, A'ishah da Costa1
1Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Insights
Antimicrobial prescribing in African paediatric wards is suboptimal, with frequent broad-spectrum agent use, delayed administration, and poor documentation. Improved stewardship is crucial for better patient outcomes.
Area of Science:
- Global Health
- Infectious Diseases
- Paediatric Medicine
Background:
- Limited data exist on antimicrobial prescribing quality in African paediatric hospitals.
- This study addresses the need for assessing antimicrobial use in neonatal and paediatric wards.
Purpose of the Study:
- To evaluate the quality of antimicrobial prescribing in neonatal and paediatric medical wards.
- To identify areas for improvement in antimicrobial stewardship.
Main Methods:
- Weekly point prevalence surveys (PPSs) were conducted over three weeks in 2025.
- Data collected included patient demographics, antimicrobial agents, prescription quality, and time to administration (hangtime).
- Electronic surveys were used to gather information from 842 prescription charts.
Main Results:
- 237 (28.1%) patients received antimicrobials, with higher use in paediatric wards (34.4%) than neonatal wards (23.3%).
- Most therapy was empiric (89.0%), with pneumonia and sepsis being common indications.
- Prescription quality was suboptimal, with documented allergies in 37.1%, infection source in 29.0%, and stop dates in 38.0%.
Conclusions:
- Antimicrobial prescribing in these wards involved frequent broad-spectrum agent use, delayed administration, and incomplete documentation.
- Findings underscore the necessity for enhanced antimicrobial stewardship practices.
- Promoting timely, appropriate, and well-documented antimicrobial use is essential.
Background:
There are limited data on antimicrobial prescribing quality in paediatric wards in African hospitals.
Objectives:
This study aimed to assess the quality of antimicrobial prescribing.
Method:
We conducted weekly point prevalence surveys (PPSs) (15 March 2025 - 05 April 2025), assessing antimicrobial use and prescribing quality in neonatal and paediatric medical wards at Tygerberg Hospital, Cape Town, South Africa. Inpatients with active antimicrobial prescriptions at 08:00 on PPS days were included, collecting data on demographics, antimicrobials, prescription quality and time to administration (hangtime) using electronic surveys.
Results:
We reviewed 842 prescription charts, of which 237 (28.1%) included antimicrobial agents (23.3% neonates vs 34.4% paediatric patients; p < 0.001). Antimicrobial use was highest in the neonatal intensive care unit (58.5%) and lowest in neonatal wards (20.0%). Most antimicrobial therapy was empiric (89.0%), with pneumonia (49.2%) leading in paediatric patients and sepsis (43.2%) in neonates. Ceftriaxone (20.9%) dominated paediatric use, while ampicillin (20.4%) and meropenem (16.7%) predominated in neonates. Overall, 49.8% of agents were 'Access', 49.3% 'Watch' and 0.9% 'Reserve' from the World Health Organization 'AWaRe' classification. The intravenous route of administration predominated (79.0%). Median treatment duration was 5 days (interquartile range [IQR] 5-7 days). In patients with sepsis, the median hangtime was 109 min (IQR 30 min - 205 min), with only 23.2% initiated within 60 min. Prescription quality was suboptimal: allergies were documented in 37.1%, infection source in 29.0% and stop dates in 38.0%.
Conclusion:
Antimicrobial prescribing in these neonatal and paediatric wards showed frequent use of broad-spectrum agents, delayed administration and incomplete documentation.
Contribution:
The findings highlight the need for improved stewardship practices to promote timely, appropriate and well-documented antimicrobial use.
More Related Videos
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Antimicrobial Effectiveness